Progressive politics presents itself as a defense of ordinary people against powerful corporations. Its legislation is sold as a way to restrain corporate excess, protect consumers, and make essentials such as health care, education, energy, housing, and insurance more affordable. That is the promise. The results have too often moved in the other direction: prices rise, choices narrow, competition weakens, and the rules grow more complex.
That pattern is not a coincidence. It is the predictable result of a system that keeps confusing regulation with competition. A rule may be written in the name of the consumer, but good intentions do not cancel its costs or change the incentives it creates. When compliance becomes expensive enough, the largest companies learn to manage it, smaller competitors struggle to enter, and the regulatory structure meant to control corporate power becomes one of its strongest defenses.
This is the central problem with progressive economic architecture. The rhetoric is aimed upward at large institutions, while the burden falls downward on families, independent businesses, and would-be competitors. A political movement can become so concerned with restraining success that it loses sight of whether its policies actually improve life for the poor and middle class. Hostility toward wealth is not the same thing as concern for the people who have the least.
The familiar term for what follows is regulatory capture. The regulated industry becomes skilled at shaping, navigating, and eventually using the regulatory system. The government gains more control, incumbent corporations gain protection from competition, and the public pays for both.
The formula is not difficult to follow. Government expands the bureaucracy, adds mandatory compliance, and requires an industry to absorb the new cost. Lower-cost alternatives are restricted or removed because they do not satisfy the new rules. Large incumbents consolidate their position because they can carry the expense, while smaller firms and new entrants cannot.
Every new layer calls for more lawyers, compliance officers, lobbyists, auditors, reporting systems, consultants, and administrative staff. A large corporation can spread those fixed costs across millions of customers. A small company cannot. The regulation may apply to both on paper, yet its real-world weight is radically different. Equal rules can create unequal burdens when only the largest players can afford the machinery required to obey them.
This is why progressives can speak the language of rebellion while governing as centralizers. They denounce concentrated corporate power and then construct the dense administrative systems that established corporations are best equipped to master. The contradiction is structural. It does not require every regulator or legislator to be corrupt, and it does not disappear because the people involved believe their intentions are humane.
Health care provides the clearest example, though it is hardly the only one. The Affordable Care Act was sold as a cost-lowering reform. Instead, it produced a more centralized insurance market in which government became more entangled, large insurers became more important, and many ordinary Americans remained exposed to severe premium, deductible, and network costs.
The ACA required a package of “essential health benefits,” standardized plans into metal tiers, and was originally enforced through an individual mandate that required people to buy coverage or pay a penalty. Some of those benefits may be valuable. The economic point is that requiring every plan to include more raises the minimum price of every compliant plan. Consumers who preferred a narrower and less expensive form of protection lost options because those options no longer satisfied the federal design.
Heavy benefit mandates combined with a required customer base also reduced some of the pressure that normally forces sellers to compete for voluntary buyers. At the same time, the cost of entering and operating in the market rose. Large insurers could build the required administrative systems or acquire competitors. Potential challengers faced a wall of fixed costs before serving their first customer. The result was fewer meaningful alternatives, greater pricing power for those that remained, and less room for genuinely different models.
Then there is the compliance burden itself. Reporting requirements, audits, prior authorizations, benefit rules, and network standards all consume labor and capital. That money does not come from nowhere. It is folded into premiums, provider charges, taxes, or some combination of the three. Calling an expense “administrative” does not keep it from landing on a household budget.
The recent premium data make the problem difficult to dismiss. For the 2026 coverage year, an analysis of filings from 312 ACA Marketplace insurers found a median requested premium increase of 18 percent, compared with 7 percent the year before. Average premiums ultimately rose by about 20 percent. Insurers identified several immediate pressures, including higher medical prices, greater use of care, expensive drugs, labor costs, inflation, provider consolidation, and federal policy changes. The numbers do not prove one political theory by themselves, but they reveal a system that remains very far from the affordability promised in its name. The Peterson–KFF analysis provides the underlying filings and methodology.
Administration is not a minor side expense. Comparative research has found that administration consumes roughly a quarter of U.S. hospital spending, more than twice the share in Canada and Scotland, without an apparent connection to better quality. Billing systems, coding, compliance, insurer negotiations, and the many rules attached to many payers create a vast apparatus around the delivery of care. The international comparison is instructive even if it does not settle every question about which reforms should follow.
Subsidies can make the immediate bill smaller for the person receiving them, but they do not make the underlying premium disappear. They move part of it to the taxpayer and can conceal how rapidly the full price is rising. When enhanced ACA tax credits expired, the difference became visible all at once. KFF estimated that subsidized enrollees’ average annual premium payments would rise from $888 in 2025 to $1,904 in 2026—a 114 percent increase—not solely because the base premium changed, but because assistance disappeared as premiums were also rising. That distinction between the price and the subsidized payment matters.
Put the premium increase in ordinary terms. A plan costing $500 a month becomes $600 after a 20 percent increase, before accounting for deductibles, copayments, or a narrower provider network. For a small-business owner or a middle-income family above a subsidy cutoff, that is not an abstract percentage. It is another $1,200 a year that cannot be spent somewhere else.
Competition also remains uneven. A Congressional Research Service review of 2025 exchange participation found that 18 percent of U.S. counties had only one or two qualified plan issuers. Some counties have more choices, and the national picture is not uniform, but a market with one or two sellers does not provide the competitive discipline consumers are usually promised. The county-level distribution makes that limitation visible.
The pattern is therefore familiar: higher premiums, fewer affordable choices, greater dependence on subsidies, and more control concentrated in large institutions. Government can still point to expanded coverage. That achievement does not answer the separate question of why the underlying system remains so expensive.
If lowering costs were the governing priority, the design would look different. It would reduce barriers to entry, make room for alternative arrangements, decentralize decision-making, and shrink the compliance load carried by every transaction. Instead, the progressive approach expands federal and state rulemaking, builds a compliance industry around providers and insurers, and creates incentives for consolidation rather than disruptive competition.
The largest firms adapt. They hire the lawyers, absorb the immediate expense, help shape the next round of rules, and pass their costs forward. Smaller competitors disappear or never form. Power moves toward the government agencies and corporations already inside the system. That is regulatory capture in practice, whether or not anyone sat in a room and consciously designed it as such.
This is where a realistic view of human nature matters. Institutions do not become wise or disinterested merely because their stated purpose is public protection. Regulators, executives, activists, and consumers all respond to the incentives placed before them. Political design must account for that fact. A system that assumes benevolent administrators can indefinitely manage a complex market from the center is not compassionate. It is careless about the limits of knowledge and power.
The first requirement is regulatory simplification. Needless mandates and duplicative compliance structures should be removed so lower-cost plans and smaller providers can exist. Protection should be judged by what it accomplishes for the patient, not by how much paperwork it produces.
Consumers also need meaningful choice in plan design and delivery. Direct primary care, telehealth, private innovation, and other alternative models should not have to fit a one-size-fits-all administrative template before they are allowed to compete. Different people face different needs and trade-offs; a functioning market gives them room to act on those differences.
Prices must become visible, and decision-making should move closer to the people affected by it. States and private institutions need room to experiment, fail, learn, and improve. Decentralization is not a guarantee that every decision will be wise. It is a way to prevent one bad decision from becoming a national command and to let better alternatives emerge.
Competition must take priority over capture. That means opening space for new entrants, confronting market dominance where government rules have entrenched it, and refusing to let incumbents turn compliance into a moat around their businesses. A market is not truly free when government has already selected who can afford to participate.
Finally, incentives should reward lower costs, better outcomes, and consumer control. Expanding required benefits can sound generous, but every benefit has a price. Serious policy has to acknowledge the trade-off rather than bury it in premiums, taxes, debt, or regulation.
None of this is a rejection of protection or health care. It is a rejection of the belief that large government regulation joined to large corporate insurance will somehow produce affordability. Too often, the opposite has followed.
The ACA is a particularly clear case of progressive policy doing what progressive policy repeatedly does: centralizing authority, raising the cost of compliance, reducing the space for alternatives, and then using subsidies to manage the expense created by the system. The moral language surrounding the policy does not alter its economic consequences.
More benefits and more regulation may sound compassionate. But when the result is higher prices, fewer choices, weaker competition, and more centralized control, the policy becomes an economic brake on the people it was supposed to help. Reality has to be allowed to judge the intention.
Civerum favors reversing that inertia: restoring market vitality, reducing regulatory drag, and allowing real competition and growth to produce better choices and prices. The health care cost crisis is not evidence that a free market failed. It is evidence of what happens when political design displaces market discipline without escaping the limits of human knowledge, institutional competence, or self-interest. Unless that architecture changes, the bills will continue to climb.
